Author:
Souglakos J,Androulakis N,Syrigos K,Polyzos A,Ziras N,Athanasiadis A,Kakolyris S,Tsousis S,Kouroussis Ch,Vamvakas L,Kalykaki A,Samonis G,Mavroudis D,Georgoulias V
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 2005
http://www.cancer.org/downloads/STT/CAFF2005f4PWsecured.pdf
. Assessed March 8, 2005
2. Bleiberg H (1998) Oxaliplatin (L-OHP): a new reality in colorectal cancer. Br J Cancer 77 (Suppl 4): 1–3
3. Caussanel JP, Lévi F, Brienza S, Misset JL, Itzhaki M, Adam R, Milano G, Hecquet B, Mathe G (1990) Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm modulated rate compared with constant rate. J Natl Cancer Inst 82: 1046–1050
4. Cox DR (1972) Regression models and life-tables. J R Stat Soc 34B: 187–220
5. de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E, Bedenne L (1997) Randomized trial comparing monthly low-dose leukovorin and fluorouracil bolus with bimonthly high dose leukovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 14: 808–815
Cited by
332 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献